Abstract
Objective and methods: Test the ability of serum uromodulin concentrations 1–3 months after renal transplantation to predict all-cause mortality (ACM) and graft loss (GL) in 91 patients. Results: uromodulin predicted GL equivalently to the other markers studied: the risk for GL was reduced by 0.21 per one standard deviation (SD) increase (cystatin C: hazard ratio [HR] 4.57, creatinine: HR 4.53, blood-urea-nitrogen [BUN]: HR 2.50, estimated glomerular filtration rate [eGFR]: HR 0.10). In receiver-operating-characteristic (ROC) analysis, uromodulin predicted GL with an area-under-the curve of 0.782 at an optimal cut-off (OCO) of 24.0 ng/ml with a sensitivity of 90.0% and a specificity of 70.2%. Conclusion: Serum uromodulin predicted GL equivalently compared to conventional biomarkers of glomerular filtration.
Original language | English |
---|---|
Pages (from-to) | 171-177 |
Number of pages | 7 |
Journal | Biomarkers |
Volume | 22 |
Issue number | 2 |
DOIs | |
State | Published - 17 Feb 2017 |
Keywords
- Biomarker
- Tamm–Horsfall protein
- cystatin C
- eGFR
- graft failure
- kidney transplantation
- proteinuria
- uromodulin